News related to Plenaxis (Abarelix) and/or conditions it is approved for
Tulane Cancer Center To Begin Novel Clinical Trial For Late-Stage Prostate Cancer Drug
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.18]
International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide.
Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies Of Apoptone (HE3235) At AACR Molecular Targets Conference
Source: Conferences News From Medical News Today [2009.11.17]
Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH), reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC).
Anxiety And Distress During Active Surveillance For Early Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.16]
UroToday.com - The present study found that the majority of men with early prostate cancer (PC) included in a protocol-based program for active surveillance (AS) show favorable anxiety and distress scores when compared to reference values and to groups of patients with PC who underwent other treatments.
Percentage Of Positive Biopsy Cores At The Onset Of Hormone Therapy For Prostate Cancer: Prognostic Significance
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.16]
UroToday.com - Accurate prediction of outcome after hormonal treatment for localized prostate cancer is important for patient counselling, follow-up, treatment planning and research protocol design. Few prognostic tools incorporating pre-therapeutic parameters are available to increase disease relapse predictions and survival.
Degarelix: A New Approach For The Treatment Of Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.16]
UroToday.com - Gonadotrophin-releasing hormone (GnRH) agonists are currently the 'standard of care' for androgen deprivation therapy (ADT) in prostate cancer. Improvements in ADT would have a great value for many patients. The agonists are associated with an initial testosterone surge, which delays castration and may stimulate tumor growth and induce 'clinical flare' in patients with symptomatic advanced disease.
Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program For TOK-001; First Ever Multi-Target Investigational Drug For Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.12]
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.06]
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.
Does Prostate-specific Antigen Velocity Help In Early Detection Prostate Cancer?
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.06]
The November issue of European Urology, the official journal of the European Association of Urology, features an article focussing on prostate specific antigen (PSA) velocity and early cancer detection. It has been suggested that changes in PSA over time aid prostate cancer detection. It is argued that a rapidly rising PSA may indicate a greater risk of diagnosis of prostate cancer even if PSA levels are low.
Moderate exercise may lower prostate cancer risk (Reuters)
Source: Y! Health Prostate Cancer News [2009.11.06]
Reuters - Men who regularly get moderate exercise may have a lower risk of developing prostate cancer -- including aggressive, fast-growing tumors, a new study finds.
Men Urged To Seek Advice Due To Faulty Prostate Cancer Home Test Kits
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.05]
Men who have used 'Simplicity Health' or 'Fortel' home testing kits for prostate cancer screening during the past 12 months are being urged to contact their GP for advice. This follows recent notification to the Medicines and Healthcare products Regulatory Agency (MHRA) that the two kits from batch number 1012 are faulty and could give a false negative result. The 1000 defective devices shipped to the UK were sold through pharmacies and via the internet.
Study Of Race, Income And Prostate Cancer Outcome
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.05]
A patient's socioeconomic status (income, marital status and race) has absolutely no impact on his outcome following curative radiation therapy for the treatment of prostate cancer, according to a new study from Henry Ford Hospital in Detroit. "This study offers an extremely important message for all patients with prostate cancer who receive radiation therapy," says Benjamin Movsas, M.D.
Time Between Treatment And PSA Recurrence Predicts Death From Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.05]
Men whose prostate specific antigen (PSA) rise within 18 months of radiotherapy are more likely to develop spread and die of their disease, according to an international study led by Fox Chase Cancer Center radiation oncologist Mark K. Buyyounouski, M.D., M.S. and presented at the annual meeting of the American Society for Radiation Oncology (ASTRO). "PSA is the gold standard for following prostate cancer patients after they receive radiation or surgery.
Blood Vessels Might Predict Prostate Cancer Behavior
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.05]
A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed? The answer may lie in the size and shape of the blood vessels that are visible within the cancer, according to research led by investigators at The Ohio State University Comprehensive Cancer Center-Arthur G.
Red, processed meats linked to prostate cancer (Reuters)
Source: Y! Health Prostate Cancer News [2009.11.05]
Reuters - Men who eat a lot of red meat and processed meats may have a higher risk of developing prostate cancer than those who limit such foods, a large study of U.S. men suggests.
Proton Boost May Thwart Prostate Cancer's Return
Source: MedicineNet Prostate Cancer Specialty [2009.11.05]
Title: Proton Boost May Thwart Prostate Cancer's Return
Category: Health News
Created: 11/5/2009 10:12:00 AM
Last Editorial Review: 11/5/2009 10:12:51 AM
Risk For High-Grade Prostate Cancer May Be Reduced By Low Cholesterol
Source: Cholesterol News From Medical News Today [2009.11.04]
Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer - an aggressive form of the disease with a poorer prognosis, according to results of a Johns Hopkins collaborative study. In a prospective study of more than 5,000 U.S. men, epidemiologists say they now have evidence that having lower levels of heart-clogging fat may cut a man's risk of this form of cancer by nearly 60 percent.
Shorter Radiation Course As Effective As Standard Therapy For Prostate Cancer Recurrence
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.04]
A shorter, five-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears to be just as effective and as safe in reducing the risk of prostate cancer from returning as standard radiation therapy, yet is delivered in two-and-a-half weeks less time, according to interim results of a randomized study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
In Prostate Cancer Patients Proton Therapy Is Well-Tolerated
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.03]
Proton beam therapy can be safely delivered to men with prostate cancer and has minimal urinary and rectal side effects, according to a study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.
Prostate Cancer Recurrences Reduced By Adding Proton Therapy "Boost" To X-Ray Radiation Therapy
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.03]
Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.
Short-Term Hormone Therapy And Intermediate Dose Radiation Increases Survivial For Early Stage Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.03]
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone, according to a Radiation Therapy Oncology Group (RTOG) study, the largest randomized trial of its kind, presented November 2, 2009, at the American Society for Radiation Oncology (ASTRO) annual meeting.
ASTRO: Hormones Plus Radiation Ups Survival in Prostate Cancer (CME/CE, with video)
Source: MedPage Today Radiology [2009.11.03]
CHICAGO (MedPage Today) -- Short-term androgen deprivation therapy significantly improved survival when added to radiation therapy for intermediate-risk prostate cancer, data from a large, multicenter clinical trial showed.
Low cholesterol may prevent some prostate cancers (AP)
Source: Y! Health Prostate Cancer News [2009.11.03]
AP - Men may protect more than their hearts if they keep cholesterol in line: Their chances of getting aggressive prostate cancer may be lower, new research suggests.
Hormone Therapy Can Help Some With Prostate Cancer
Source: MedicineNet Hormone Therapy Specialty [2009.11.03]
Title: Hormone Therapy Can Help Some With Prostate Cancer
Category: Health News
Created: 11/2/2009 2:10:00 PM
Last Editorial Review: 11/3/2009
Hormone Therapy Can Help Some With Prostate Cancer (HealthDay)
Source: Y! Health Cervical Cancer News [2009.11.02]
HealthDay - MONDAY, Nov. 2 (HealthDay News) -- A brief course of hormone-blocking
therapy can provide small benefits to a specific group of men who get
radiation therapy for prostate cancer, a long-running study shows.
New Test Checks for Prostate Cancer Return
Source: MedicineNet Mens Health Specialty [2009.10.20]
Title: New Test Checks for Prostate Cancer Return
Category: Health News
Created: 10/20/2009 11:07:00 AM
Last Editorial Review: 10/20/2009 11:07:22 AM
Exercise May Prevent Prostate Cancer: Study
Source: MedicineNet Prostate Cancer Specialty [2009.09.28]
Title: Exercise May Prevent Prostate Cancer: Study
Category: Health News
Created: 9/25/2009 4:10:00 PM
Last Editorial Review: 9/28/2009
Hormone Therapy for Prostate Cancer Raises Heart Risks
Source: MedicineNet Hormone Therapy Specialty [2009.09.23]
Title: Hormone Therapy for Prostate Cancer Raises Heart Risks
Category: Health News
Created: 9/22/2009 2:10:00 PM
Last Editorial Review: 9/23/2009
STD Linked to Prostate Cancer
Source: MedicineNet Prostate Specific Antigen Specialty [2009.09.14]
Title: STD Linked to Prostate Cancer
Category: Health News
Created: 9/14/2009 11:22:00 AM
Last Editorial Review: 9/14/2009 11:22:01 AM
Prostate Cancer Over-Diagnosed: Study
Source: MedicineNet Urinary Incontinence Specialty [2009.09.01]
Title: Prostate Cancer Over-Diagnosed: Study
Category: Health News
Created: 8/31/2009 4:10:00 PM
Last Editorial Review: 9/1/2009
Hormone Therapy for Early Prostate Cancer Not Always Best
Source: MedicineNet Hormone Therapy Specialty [2009.08.26]
Title: Hormone Therapy for Early Prostate Cancer Not Always Best
Category: Health News
Created: 8/25/2009 4:10:00 PM
Last Editorial Review: 8/26/2009
Erectile Aid Use By Men Treated For Localized Prostate Cancer
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.08.10]
UroToday.com - A UCLA single-institution study in the online edition of the Journal of Urology reports on the use of erectile aid (EA) following treatment for localized prostate cancer (CaP). Participants with a diagnosis of CaP were prospectively recruited between 1999 and 2003. Clinical and pathological data was abstracted and HRQOL (Health Related Quality of Life) outcomes were prospectively abstracted at baseline and 1, 2, 4, 8, 12, 18, 24, 30, 36, 42 and 48 months.
Oncological Results, Functional Outcomes, Quality-of-Life - Radical Prostatectomy Or External Beam Radiation Therapy For Localized Prostate Cancer
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.08.03]
UroToday.com - Most recently, health-related quality-of-life (HRQOL) after definitive local therapy for prostate cancer has been argued in the patient group with an oncological risk category.
Men Who Have Prostate Cancer Surgery Do Well
Source: MedicineNet Urinary Incontinence Specialty [2009.07.28]
Title: Men Who Have Prostate Cancer Surgery Do Well
Category: Health News
Created: 7/28/2009 7:00:00 AM
Last Editorial Review: 7/28/2009
Green Tea Component May Slow Prostate Cancer
Source: MedicineNet Prostate Specific Antigen Specialty [2009.06.22]
Title: Green Tea Component May Slow Prostate Cancer
Category: Health News
Created: 6/20/2009 7:00:00 AM
Last Editorial Review: 6/22/2009
Study Details Quality Of Life For Prostate Cancer Patients Four Years Out From Treatment
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.06.10]
A long-term study by researchers at UCLA's Jonsson Comprehensive Cancer Center found that the three most common treatments for localized prostate cancer had significant impacts on patients' quality of life, a finding that could help guide doctors and patients in making treatment decisions.
Gene Test Helps Detect Prostate Cancer
Source: MedicineNet Prostate Specific Antigen Specialty [2009.06.01]
Title: Gene Test Helps Detect Prostate Cancer
Category: Health News
Created: 6/1/2009 7:00:00 AM
Last Editorial Review: 6/1/2009
Prostate Cancer Vaccine Meets Goal
Source: MedicineNet Tremor Specialty [2009.04.15]
Title: Prostate Cancer Vaccine Meets Goal
Category: Health News
Created: 4/15/2009
Last Editorial Review: 4/15/2009
Folic Acid May Raise Prostate Cancer Risk
Source: MedicineNet Colon Polyps Specialty [2009.03.11]
Title: Folic Acid May Raise Prostate Cancer Risk
Category: Health News
Created: 3/11/2009
Last Editorial Review: 3/11/2009
Drug May Help Prevent Prostate Cancer
Source: MedicineNet Benign Prostatic Hyperplasia Specialty [2009.02.25]
Title: Drug May Help Prevent Prostate Cancer
Category: Health News
Created: 2/25/2009
Last Editorial Review: 2/25/2009
Degarelix Approved for Advanced Prostate Cancer
Source: MedicineNet leuprolide Specialty [2008.12.30]
Title: Degarelix Approved for Advanced Prostate Cancer
Category: Health News
Created: 12/30/2008 2:00:00 AM
Last Editorial Review: 12/30/2008
Treatment Options Are Many for Prostate Cancer
Source: MedicineNet Overactive Bladder Specialty [2008.12.08]
Title: Treatment Options Are Many for Prostate Cancer
Category: Health News
Created: 12/6/2008 2:00:00 AM
Last Editorial Review: 12/8/2008
Prostate Cancer Therapy May Not Help
Source: MedicineNet leuprolide Specialty [2008.07.09]
Title: Prostate Cancer Therapy May Not Help
Category: Health News
Created: 7/9/2008
Last Editorial Review: 7/9/2008
Prostate Cancer
Source: MedicineNet Hydronephrosis Specialty [2007.06.04]
Title: Prostate Cancer
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 6/4/2007
Lifestyle, diet may stop or reverse prostate cancer progression
Source: The Doctors Lounge - Urology
The research is the first randomized, controlled trial to show that lifestyle changes may affect cancer progression.
Routine Evaluation Of Prostate Size Not As Effective In Cancer Screening, Mayo Study Finds
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.11]
New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer.
ASTRO: Blood Thinners May Lower PSA Failure Risk (CME/CE, with video)
Source: MedPage Today Hematology/Oncology [2009.11.10]
CHICAGO (MedPage Today) -- Patients with localized prostate cancer had significantly better biochemical control if they were taking an anticoagulant or antiplatelet agent following radiation therapy, according to a study reported here.
New Finding Suggests Prostate Biopsy Is Not Always Necessary
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.07]
Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy. Elevated levels of PSA have traditionally been seen as a potential sign of prostate cancer, leading to the widespread use of PSA testing.
ASTRO: Early PSA Rise Predicts Mortality (CME/CE)
Source: MedPage Today Radiology [2009.11.06]
CHICAGO (MedPage Today) -- A rising PSA value within 18 months of radiation therapy predicts an increased risk of prostate cancer metastasis and mortality, data from a retrospective study showed.
ASTRO: Statins May Boost Effects of Prostate Radiation (CME/CE)
Source: MedPage Today Radiology [2009.11.05]
CHICAGO (MedPage Today) -- Prostate cancer patients had a reduced risk of biochemical failure if they were taking a statin during radiation therapy, data from a retrospective cohort study showed.
Answers And Some New Questions Concerning Cholesterol And Cancer
Source: Cholesterol News From Medical News Today [2009.11.04]
A pair of studies in Cancer Epidemiology, Biomarkers & Prevention, lay to rest the decades-long concern that lower total cholesterol may lead to cancer, and in fact lower cholesterol may reduce the risk of high-grade prostate cancer. Demetrius Albanes, M.D., a senior investigator at the National Cancer Institute, said early studies suggested that low cholesterol could increase the risk of certain types of cancer.
Studies Negate Concerns That Low Cholesterol Leads To Some Cancers
Source: Cholesterol News From Medical News Today [2009.11.04]
Two new studies from the US published this week negate concerns that have been around since early studies done decades ago suggested that low cholesterol leads to some types of cancer: one in fact affirms that undiagnosed cancer is the likely cause of lower total cholesterol while the other found evidence linking low cholesterol and decreased risk of high-grade prostate cancer among older men.
PSA Reading Could Predict Post-Radiation Survival (HealthDay)
Source: Y! Health Prostate Cancer News [2009.11.04]
HealthDay - WEDNESDAY, Nov. 4 (HealthDay News) -- Prostate cancer patients
whose prostate-specific antigen (PSA) levels rise within 18 months after
radiotherapy have an increased risk of death, say U.S. researchers.
Undetectable PSA After Radiation Is Possible And Predicts Good Patient Outcomes
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.03]
Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured. The data was presented at the annual meeting of the American Society for Radiation Oncology.
November Is Lung Cancer Month: Know The Latest Information About This Deadliest Of Cancers
Source: Lung Cancer News From Medical News Today [2009.10.29]
Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected to be diagnosed this year.(1) It is also estimated that lung cancer will cause 159,000 deaths in the United States this year - more than the total number of deaths resulting from breast, colon and prostate cancers combined.
|
